News

Researchers have shown that by administering an immune checkpoint inhibitor to prime the tumor environment prior to a multikinase inhibitor, it's possible to boost the effectiveness of existing therapeutics for hepatocellular carcinoma.

A Phase I clinical trial will explore the safety and immunogenicity of three preventive HIV vaccines using mRNA technology.

Mutations that lead to muscle atrophy can be repaired with the gene editor CRISPR-Cas9. A team led by ECRC researcher Helena Escobar has now introduced the tool into human muscle stem cells for the first time using mRNA, thus discovering a method suitable for therapeutic applications.

Planned movement is essential to our daily lives, and it often requires delayed execution. As children, we stood crouched and ready but waited for the shout of “GO!” before sprinting from the starting line. Now, scientists have discovered the brain network that turns plans into action in response to this cue.

A team has begun to unravel the mystery of why a particular form of leukemia in infants has defied efforts to improve outcomes, despite improvements being made for older children.

Researchers have developed a new method for training people to be creative, one that shows promise of succeeding far better than current ways of sparking innovation.

Researchers have confirmed that mice perceive the inherent difference between a picture of an object and the actual 3D object itself.

According to a study, cognitive decline is the biggest factor in determining how long patients with Alzheimer’s disease will live after being diagnosed.

Researchers have developed a new strategy for vaccine delivery by embedding the SARS-CoV-2 spike protein into red blood cell membranes.

A new hypothesis suggests that oxygen finally started accumulating in Earth's atmosphere 2.3 billion years ago thanks to interactions between certain marine microbes and minerals in ocean sediments.